BOSTON, May 20, 2019 /PRNewswire/ -- CSA Medical today announced the presentation of three clinical abstracts highlighting truFreeze® Spray Cryotherapy for treatment of Barrett's esophagus (BE).
- Study results highlight the use of truFreeze as the only FDA-cleared minimally-invasive spray cryotherapy platform that offers clinical benefit across the esophageal disease spectrum - from ...
BALTIMORE, Md.--(BUSINESS WIRE)--CSA Medical, Inc. unveiled the new truFreeze® Spray Cryotherapy System this week at the Digestive Disease Week (DDW) 2012 Annual Meeting in San Diego. The truFreeze ...
BOSTON, Oct. 2, 2017 /PRNewswire/ -- CSA Medical announced today that the first patient treatment using the new Rapid AV Spray Catheter was completed at the University of Rochester Medical Center by ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to add Barrett’s esophagus with low-grade dysplasia to the label of CSA ...
- Data show safe and effective palliation prior to chemoradiotherapy for treatment-naïve esophageal cancer patients who presented with dysphagia at diagnosis - The authors concluded that liquid ...
The compact, lightweight UltraFreeze is the new, easy-to-use, portable cryosurgical system ideal for most office skin procedures. The newly designed ergonomic handle offers comfort and control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback